Develops affordable, orally delivered biologic drugs using spirulina to treat diseases like C. difficile and inflammatory bowel disease.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Lumen Bioscience develops and manufactures biologic drugs using patented technology that harnesses the food algae spirulina to deliver therapeutic proteins. The company focuses on creating affordable, scalable, and orally delivered biologics for diseases with high unmet needs, such as metabolic disease, C. difficile infection, and inflammatory bowel disease.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Lumen Bioscience Management Team
Investors
Avista Development
Bioeconomy Capital
Columbia Pacific Capital Management
WestRiver Management
Lumen Bioscience Valuations & Financials
View real-time NPM data on Lumen Bioscience stock including daily Lumen Bioscience stock price estimates, valuation history, and historical share price information. Access Lumen Bioscience financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Lumen Bioscience pricing across six independent market signals. Looking for private company due diligence data sources on Lumen Bioscience? Get in touch to learn more.
Similar Companies
like Lumen Bioscience
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Wheel Health
Healthcare & Life Sciences
Telehealth platform providing virtual care infrastructure and clinician network to help organizations deliver and scale digital health services.
Twenty
Industrializing offensive cyber capabilities for the U.S. military and Intelligence Community.
The Bounty App
Media & Entertainment
A creator monetization platform that connects influencers with brands, facilitating paid collaborations and product promotions on social media.
Neighbor
Connects people needing storage or parking with neighbors offering unused space for belongings or vehicles, all booked easily online.
Inflammatix
Healthcare & Life Sciences
Develops rapid tests that analyze the immune system to diagnose acute infections and sepsis.
Planted Solar
Delivers a platform combining software, adaptive solar arrays, and automation for faster, more efficient, and cost-effective solar power plants.
Chili Piper
Enterprise Software
B2B platform that automates lead qualification, routing and scheduling to streamline marketing-to-sales conversion processes.
ViaBot
Provides autonomous, self-charging sweeping robots that clean, map, and monitor facilities while delivering operational insights.
FAQ
We have answers
Lumen Bioscience stock does not trade on public stock exchanges. Lumen Bioscience stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Lumen Bioscience stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Lumen Bioscience Stock does not trade on public stock exchanges. In order to sell Lumen Bioscience shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Lumen Bioscience does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Lumen Bioscience share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Lumen Bioscience stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Lumen Bioscience stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Lumen Bioscience stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Lumen Bioscience is a private company and has not had an IPO. There is currently no Lumen Bioscience IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Lumen Bioscience IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
